India drugmaker stocks exception in Asian rout
In Mumbai trading so far this year, Lupin Ltd has climbed 32 percent, Dr. Reddy`s 31 percent, Glenmark Pharmaceuticals 42 percent and Wockhardt 29 percent.
Sep 03, 2015, 19:37 PM IST
Sun Pharma may file new drug application with USFDA: Shanghvi
India's largest drugmaker Sun Pharma may file application for a new drug with the US Food and Drug Administration in next two to three years, the company's Managing Director Dilip Shanghvi said on Thursday.
Jul 30, 2015, 20:47 PM IST
Sun Pharma slumps, heads towards biggest fall ever
Shares in Sun Pharmaceutical Industries slumped 16 percent, heading towards their biggest daily fall ever, after the drugmaker on Monday said it sees 2016 sales flat at best.
Jul 21, 2015, 09:42 AM IST
Lupin shares gain on inclusion in Sensex
Shares of drugmaker Lupin rose by almost 2 percent after the stock became part of the BSE benchmark Sensex from on Monday.
Jun 22, 2015, 13:16 PM IST
Sun Pharma Q3 net profit declines 7% to Rs 1,425 crore
Drug major Sun Pharma on Saturday reported 6.92 percent decline in consolidated net profit at Rs 1,425.07 crore for the third quarter ended December 31, 2014-15, saying it was hit by supply constraints.
Feb 14, 2015, 16:14 PM IST
HC stays suspension order of Maha FDA on Dr Reddy's C&F agent
Dr Reddy's Laboratories on Friday said the Bombay High Court has granted an interim stay on an order issued by the Maharashtra drug controller (FDA) for a one-month suspension of wholesale licence of the company's clearing and forwarding agent in Bhiwandi near Thane.
Jan 09, 2015, 14:18 PM IST
Lupin Q1 net profit up 56% on higher US drug sales
Lupin Ltd , India`s fourth-largest drugmaker by sales, reported a higher-than-expected profit in the first quarter, helped mainly by higher sales in the United States and India, and lower expenses.
Jul 30, 2014, 14:05 PM IST
